Ptc Therapeutics (PTCT) Current Assets (2012 - 2026)

Ptc Therapeutics' Current Assets history runs 15 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• On a quarterly basis, Current Assets fell 2.69% year-over-year to $2.3 billion in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 2.69% decrease from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 66.52% from the prior year.
• Current Assets eased to $2.3 billion in Q1 2026 per PTCT's latest filing, from $2.3 billion in the prior quarter.
• Across five years, Current Assets topped out at $2.3 billion in Q1 2025 and bottomed at $517.3 million in Q3 2022.
• The 5-year median for Current Assets is $1.2 billion (2023), against an average of $1.3 billion.
• Across the five-year window, Current Assets sank 48.84% in 2022 and soared 137.17% in 2024, its largest moves.
• Year by year, Current Assets stood at $693.8 million in 2022, then jumped by 75.65% to $1.2 billion in 2023, then climbed by 12.05% to $1.4 billion in 2024, then surged by 66.52% to $2.3 billion in 2025, then declined by 0.88% to $2.3 billion in 2026.
• Per Business Quant, the three latest PTCT Current Assets figures stand at $2.3 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.0 billion (Q3 2025).